Drug interaction study of ECC0509 with common medicines
Part of Digestive system clinical trials.
This trial checks how a new medicine, ECC0509, interacts with common drugs like metformin, midazolam, and caffeine in healthy adults. It helps find safe dosing and possible side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old.
- Be generally healthy with no major medical conditions.
- Not take any prescription or over-the-counter drugs for 7 days before the trial starts.
- Avoid more than 2 caffeinated drinks a day for the past month and be willing to limit them during the trial.
- Drink no more than 10 alcoholic drinks per week and no more than 4 in a day.
- Have no history of drug abuse, significant psychiatric disorders, or recent surgery or hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests how a new drug (ECC4703) works in the body when taken with two other common medications (sulfasalazine and pitavastatin). Healthy volunteers are needed to help researchers understand potential drug interactions and safety.
This early-stage study tests a new drug called EQ504 in healthy volunteers to see how safe it is and how the body handles it. Participants receive either the drug or a placebo (inactive substance), and the study helps determine the right dose for future research.
This trial tests how taking the study drug ECC4703 with or without food affects its levels in the body, and how well the body absorbs it. It helps find the best way to take the drug.
This trial tests how a new drug, E2086, interacts with other medicines in healthy volunteers. It helps make sure the drug is safe and works properly when combined with common medications.
This early-stage study checks if a new medicine called HEC169584 is safe for people and how it moves through the body. It looks for healthy volunteers to take part.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
Hear when a new Steatohepatitis, Nonalcoholic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.